Delivery Order SPE2DB24D2205-SPE2DB25FEDRR

Award Date 6/13/25
Potential Completion Date 7/8/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,590.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a performance period ending on July 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a completion date of July 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $8,590.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through April 18, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,771.74, is for the delivery of OFEV 150 MG CAPSULE 60S and has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a $8,630.28 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OFEV 100 MG CAPSULE 60S. The award has a completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
This is a $8,590.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a prescription medication, with a performance period through July 10, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,771.74, is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $34,481.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OFEV 100 MG CAPSULE 60S, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 26, 2025 and was awarded on March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a $7,905.56 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,630.28 firm fixed-price contract is for the delivery of OFEV 100 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEDRR
    Delivery Order

This is a $34,362.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs. This delivery order is not designated as a set-aside contract, indicating open competition. The company's federal contract awards predominantly involve the supply of a wide range of pharmaceutical and medical products to various government agencies, including medications across multiple therapeutic domains.

Generated 9/12/25, 10:50 AM